LABIANA HEALTH S.A.EO-10 (8RK) — Tangible Net Worth Ratio
LABIANA HEALTH S.A.EO-10 (8RK) has a Tangible Net Worth Ratio of -65.0% as of June 2025. This metric is calculated by deducting intangible assets (€5.95 Million) from net assets (€3.60 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 8RK net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
LABIANA HEALTH S.A.EO-10 Tangible Net Worth Ratio (2021–2024)
This chart shows how LABIANA HEALTH S.A.EO-10's Tangible Net Worth Ratio has changed across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at -65.0%, reflecting net assets of €3.60 Million with intangible assets of €5.95 Million EUR. For live market cap and overall valuation, see LABIANA HEALTH S.A.EO-10 (8RK) total market value.
Annual Tangible Net Worth Ratio for LABIANA HEALTH S.A.EO-10 (2021–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for LABIANA HEALTH S.A.EO-10 from 2021 to 2024, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore LABIANA HEALTH S.A.EO-10 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -134.7% | €2.57 Million | €6.03 Million | €52.00 Million | ▼ -9.0 pp |
| 2023 | -125.6% | €3.40 Million | €7.68 Million | €59.12 Million | ▼ -94.7 pp |
| 2022 | -31.0% | €6.91 Million | €9.04 Million | €60.78 Million | ▼ -31.5 pp |
| 2021 | 0.5% | €11.52 Million | €11.46 Million | €68.37 Million | — |